Australia's Sigma Healthcare falls after Jefferies trims PT on slower Chemist Warehouse sales growth

By Reuters News

** Shares of Australia's Sigma Healthcare SIG.AX fall as much as 5.1% to A$2.685, their biggest intraday pct drop since August 27

** Stock hits its lowest level since October 12

** Jefferies cuts its price target on the pharmacy retailer to A$3.15 from A$3.20 after the company's AGM update showed Australian Chemist Warehouse like-for-like sales growth slowed to 9.8% in FY27 year-to-date from 13.4% in FY26

** Brokerage says softer discretionary spending and fading impact of an initial GLP-1 sales boost weighed on Australian growth, though international operations accelerated

** Jefferies cuts its FY27 EPS forecast by about 2% and FY28 EPS forecast by about 3%

** Sigma stock down 6.6%, YTD, including session moves

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk